Amatuximab for High Mesothelin Cancers

Clinical trial NCT01413451 · TERMINATED

Trial details

NCT number: NCT01413451
Sponsor: National Cancer Institute (NCI)
Status: TERMINATED
Phase: Early Phase 1
Study type: INTERVENTIONAL

Carcinoma, Pancreatic Ductal Mesothelioma Ovarian Neoplasms Carcinoma, Non-Small-Cell Lung

Start date: 2011-07-12
Primary completion: 2013-11-15
Enrollment: 7

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.